More articles from Reviews

Human lipopolysaccharide models provide mechanistic and therapeutic insights into systemic and pulmonary inflammation
Daniel Brooks, Laura C. Barr, Sarah Wiscombe, Daniel F. McAuley, A. John Simpson, Anthony J. Rostron

European Respiratory Journal Jul 2020, 56 (1) 1901298; DOI: 10.1183/13993003.01298-2019
Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Fredrikus A. Klok, Francis Couturaud, Marion Delcroix, Marc Humbert

European Respiratory Journal Jun 2020, 55 (6) 2000189; DOI: 10.1183/13993003.00189-2020
Clinical considerations in individuals with α₁-antitrypsin PI*SZ genotype
Gerard N. McElvaney, Robert A. Sandhaus, Marc Miravitlles, Gerard M. Turino, Niels Seersholm, Marion Wencker, Robert A. Stockley

European Respiratory Journal Jun 2020, 55 (6) 1902410; DOI: 10.1183/13993003.02410-2019
Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19
Maroun Khoury, Jimena Cuenca, Fernanda F. Cruz, Fernando E. Figueroa, Patricia R.M. Rocco, Daniel J. Weiss

European Respiratory Journal Jun 2020, 55 (6) 2000858; DOI: 10.1183/13993003.00858-2020
Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis
Martino F. Pengo, Davide Soranna, Alice Giontella, Elisa Perger, Paola Mattaliano, Esther Irene Schwarz, Carolina Lombardi, Grzegorz Bilo, Antonella Zambon, Joerg Steier, Gianfranco Parati, Pietro Minuz, Cristiano Fava

European Respiratory Journal May 2020, 55 (5) 1901945; DOI: 10.1183/13993003.01945-2019
Asthma progression and mortality: the role of inhaled corticosteroids
Paul O'Byrne, Leonardo M. Fabbri, Ian D. Pavord, Alberto Papi, Stefano Petruzzelli, Peter Lange

European Respiratory Journal Jul 2019, 54 (1) 1900491; DOI: 10.1183/13993003.00491-2019
Moving target: shifting the focus to pulmonary sarcoidosis as an autoimmune spectrum disorder
Ylva Kaiser, Anders Eklund, Johan Grunewald

European Respiratory Journal Jul 2019, 54 (1) 1802153; DOI: 10.1183/13993003.021532018
Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation
John Efthimiou, Chris Poll, Peter J. Barnes

European Respiratory Journal Jul 2019, 54 (1) 1802390; DOI: 10.1183/13993003.02390-2018
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Dave Singh, Alvar Agusti, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Gerard J. Criner, Peter Frith, David M.G. Halpin, Meilan Han, M. Victorina López Varela, Fernando Martinez, Maria Montes de Oca, Alberto Papi, Ian D. Pavord, Nicolas Roche, Donald D. Sin, Robert Stockley, Jørgen Vestbo, Jadwiga A. Wedzicha, Claus Vogelmeier

European Respiratory Journal May 2019, 53 (5) 1900164; DOI: 10.1183/13993003.00164-2019
Immediate bronchodilator response in FEV₁ as a diagnostic criterion for adult asthma
Leena E. Tuomisto, Pinja Ilmarinen, Lauri Lehtimäki, Minna Tommola, Hannu Kankaanranta

European Respiratory Journal Feb 2019, 53 (2) 1800904; DOI: 10.1183/13993003.00904-2018

Main menu

User menu

Search

More articles from Reviews

Pages

Contact us